ArticleTrials2025

Dermatitis during adjuvant irradiation for breast cancer (DAI-BREAC): a randomized controlled trial investigating whether grade ≥2 dermatitis during radiotherapy for breast cancer can be reduced by a mobile application that reminds patients to perform skin care.

Dirk Rades et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.